An AllTrials project

NCT05802173: An overdue trial by Technoderma Medicines Inc.

This trial is overdue. It was due to report 11 months, 2 weeks ago.

Think we've made a mistake? Before contacting us, review the criteria in our paper. In particular, bear in mind the following:

  • We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
  • Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
  • Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.

Full data

Full entry on ClinicalTrials.gov NCT05802173
Title A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects with Androgenetic Alopecia
Results Status Overdue
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date March 6, 2023
Completion date Nov. 8, 2023
Required reporting date Nov. 7, 2024, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Sept. 16, 2025
Days late 312